Results 211 to 220 of about 885,457 (308)
Green "turn-off" luminescent nanosensor for the sensitive analysis of finerenone in various matrices: application of recent greenness assessment techniques. [PDF]
Ali MB +5 more
europepmc +1 more source
Model‐informed precision dosing (MIPD) of tacrolimus in renal allograft recipients, evaluated in silico, demonstrated improved (time to and) probability of target concentration attainment and smaller deviations from target range. Using simulated tacrolimus concentration‐time profiles, a study of 200 patients was predicted to have sufficient power to ...
Dirk R.J. Kuypers +6 more
wiley +1 more source
Chemical Bonding: A First-Year Seminar Series that Enhances Chemistry Majors' Perceptions of Chemistry Subdisciplines. [PDF]
Saenger SL +3 more
europepmc +1 more source
Large Language Models for Clinical Trial Protocol Assessments
The purpose was to evaluate the utility of large language models (LLMs) for reviewing the statistical analysis plan (SAP) and pharmacokinetics–pharmacodynamics (PK–PD) components of clinical trial protocols. Clinical trial protocols and SAPs were obtained from clinicaltrials.gov for a testbed of 15 small‐molecule drugs, biologics, and global antibiotic
Euibeom Shin +2 more
wiley +1 more source
Sustainable HPLC method for simultaneous determination of Cefazolin, Sulfadimidine, and Marbofloxacin residues in milk. [PDF]
Hammad SF +3 more
europepmc +1 more source
The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System ...
Charles Khouri +7 more
wiley +1 more source
Journal of Analytical Methods in Chemistry
doaj +1 more source
Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
Optimized dosing precision of antibody–drug conjugates (ADCs) remains challenging due to narrow therapeutic indices, efficacious doses near the maximum tolerated dose, and substantial interindividual variability in exposure. Body size‐based dosing can reduce exposure variability when the allometric scaling exponent for clearance α = 1 but may over‐ or ...
Andrew B. SyBing, Diane D. Wang
wiley +1 more source

